Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Change in Account Payables: 2015-2024

Historic Change in Account Payables for AC Immune (ACIU) over the last 10 years, with Dec 2024 value amounting to $1.1 million.

  • AC Immune's Change in Account Payables fell 5161.39% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $592,413, marking a year-over-year increase of 3219.50%. This contributed to the annual value of $1.1 million for FY2024, which is 28.48% up from last year.
  • Latest data reveals that AC Immune reported Change in Account Payables of $1.1 million as of FY2024, which was up 28.48% from $868,063 recorded in FY2023.
  • AC Immune's Change in Account Payables' 5-year high stood at $2.4 million during FY2020, with a 5-year trough of -$1.1 million in FY2022.
  • Moreover, its 3-year median value for Change in Account Payables was $868,063 (2023), whereas its average is $289,844.
  • Per our database at Business Quant, AC Immune's Change in Account Payables skyrocketed by 229.18% in 2020 and then crashed by 1,111.63% in 2022.
  • Yearly analysis of 5 years shows AC Immune's Change in Account Payables stood at $2.4 million in 2020, then plummeted by 103.82% to -$91,925 in 2021, then tumbled by 1,111.63% to -$1.1 million in 2022, then surged by 177.94% to $868,063 in 2023, then grew by 28.48% to $1.1 million in 2024.